Blog

On April 22, 2020, Dr. Chunlin Chen, founder and CEO of Medicilon, delivered a special lecture entitled “Application of Translational Medicine (PDX Model) in the Research and Development of New Immune Cancer Drugs” Run Run Shaw Hospital affiliated to Medical College of Zhejiang University . The medical staff and medical students of the company sharedRead more

As the incidence and mortality of cancer have increased year by year, cancer has become the primary enemy threatening human health. Therefore, more and more researchers have invested in the exploration of cancer pathogenesis and new treatments. Despite this, only a handful of new anti-cancer drugs are approved every year. The main reason is thatRead more

Clinical cancer research is a rapidly evolving industry, with personalized medicine now at the forefront of clinical trials. The promise of profiling a patient’s genetic makeup to guide the drugs or treatments to either choose a more successful result or to minimize unpleasant or harmful side effects has obvious benefits. Another key goal for personalizedRead more